Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

Antitrust

Venture Capital

We have extensive experience in venture capital and growth equity transactions, representing both providers and seekers of venture and growth capital.

In serving our clients, we draw on our broad public company and mergers and acquisitions (M&A) experience to implement the growth and eventual exit strategies of our clients. This experience allows us to efficiently represent our venture-backed clients in even the most complex liquidation events, in whatever form they may take—recapitalization, stock or asset sale or initial public offering (IPO). As a full-service firm, we also offer growth and venture-stage companies guidance on a broad range of important legal matters relating to their business activities, including the acquisition and protection of intellectual property, environmental law compliance, commercial loan transactions, labor and employment matters, taxation and dispute resolution.

We have extensive experience in venture capital and growth equity transactions, representing both providers and seekers of venture and growth capital.

In serving our clients, we draw on our broad public company and mergers and acquisitions (M&A) experience to implement the growth and eventual exit strategies of our clients. This experience allows us to efficiently represent our venture-backed clients in even the most complex liquidation events, in whatever form they may take—recapitalization, stock or asset sale or initial public offering (IPO). As a full-service firm, we also offer growth and venture-stage companies guidance on a broad range of important legal matters relating to their business activities, including the acquisition and protection of intellectual property, environmental law compliance, commercial loan transactions, labor and employment matters, taxation and dispute resolution.

As a result of the depth and breadth of our experience, and the extensive network we have developed in the venture capital and growth equity community, we also play an active role in introducing entrepreneurs and venture and growth capital firms.

With offices in Nashville and Washington, D.C., our experience in healthcare venture capital transactions is particularly robust. We provide our healthcare venture capital and growth equity clients with a fully-integrated range of services that includes an effective blend of transactional, regulatory and operational counsel. We routinely assist clients with comprehensive due diligence to help them understand key issues and regulatory risks associated with an investment. We also assist our venture capital and growth equity firm clients and emerging growth companies in healthcare investigations and as compliance counsel.

Representative services and experience:

  • Venture and growth equity financings 
  • Leveraged dividends and recapitalizations 
  • Minority interest transactions 
  • "Add on" acquisitions 
  • Due diligence and risk analysis 
  • Healthcare investigations, regulatory and operational counsel 
  • Corporate/general counsel, and
  • M&A, IPO and "exit transaction" services. 

+ Read More

- Read Less

News

View More

Related Experiences

View More

Related Professionals

NAME TITLE TELEPHONE CONTACT

Viewing 0 of 0 Results

View More

Publications

View More

Past Events

View More

Media Mentions

View More

Services

×

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.